Direct-to-consumer advertising - A haphazard approach to health promotion

被引:73
作者
Hollon, MF [1 ]
机构
[1] Univ Washington, Dept Med, Seattle, WA 98105 USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2005年 / 293卷 / 16期
关键词
D O I
10.1001/jama.293.16.2030
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2030 / 2033
页数:4
相关论文
共 41 条
[1]  
[Anonymous], 2001, PRESCR DRUGS MASS ME
[2]  
AVORN J, 2003, HLTH AFF MILLWO 0226
[3]  
Bell RA, 2000, J FAM PRACTICE, V49, P1092
[4]  
BODENHEIMER T, 2003, HLTH AFF MILLWO 0226
[5]   National trends in cyclooxygenase-2 inhibitor use since market release - Nonselective diffusion of a selectively cost-effective innovation [J].
Dai, CL ;
Stafford, RS ;
Alexander, C .
ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (02) :171-177
[6]   Effects of pharmaceutical promotion on adherence to the treatment guidelines for depression [J].
Donohue, JM ;
Berndt, ER ;
Rosenthal, M ;
Epstein, AM ;
Frank, RG .
MEDICAL CARE, 2004, 42 (12) :1176-1185
[7]  
DUBOIS RW, 2003, HLTH AFF MILLWO 0226
[8]  
ELLIOTT VS, 2003, AM MED NEWS 0203, P28
[9]  
ELLIOTT VS, 2003, AM MED NEWS 0203, P25
[10]  
FEDER BJ, 2005, NY TIMES 0217, pC1